NM_001256317.3:c.453G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001256317.3(TMPRSS3):​c.453G>A​(p.Val151Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 1,612,724 control chromosomes in the GnomAD database, including 121,065 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.48 ( 20835 hom., cov: 32)
Exomes 𝑓: 0.36 ( 100230 hom. )

Consequence

TMPRSS3
NM_001256317.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.09

Publications

33 publications found
Variant links:
Genes affected
TMPRSS3 (HGNC:11877): (transmembrane serine protease 3) This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
TMPRSS3 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 21-42385528-C-T is Benign according to our data. Variant chr21-42385528-C-T is described in ClinVar as Benign. ClinVar VariationId is 46122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.804 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS3NM_001256317.3 linkc.453G>A p.Val151Val synonymous_variant Exon 6 of 13 ENST00000644384.2 NP_001243246.1 P57727-5
TMPRSS3NM_024022.4 linkc.453G>A p.Val151Val synonymous_variant Exon 6 of 13 NP_076927.1 P57727-1
TMPRSS3NM_032405.2 linkc.453G>A p.Val151Val synonymous_variant Exon 6 of 9 NP_115781.1 P57727-3
TMPRSS3NM_032404.3 linkc.72G>A p.Val24Val synonymous_variant Exon 3 of 10 NP_115780.1 P57727-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS3ENST00000644384.2 linkc.453G>A p.Val151Val synonymous_variant Exon 6 of 13 NM_001256317.3 ENSP00000494414.1 P57727-5

Frequencies

GnomAD3 genomes
AF:
0.478
AC:
72603
AN:
151956
Hom.:
20783
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.811
Gnomad AMI
AF:
0.295
Gnomad AMR
AF:
0.412
Gnomad ASJ
AF:
0.380
Gnomad EAS
AF:
0.281
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.357
Gnomad OTH
AF:
0.473
GnomAD2 exomes
AF:
0.360
AC:
90420
AN:
251436
AF XY:
0.352
show subpopulations
Gnomad AFR exome
AF:
0.823
Gnomad AMR exome
AF:
0.300
Gnomad ASJ exome
AF:
0.376
Gnomad EAS exome
AF:
0.267
Gnomad FIN exome
AF:
0.281
Gnomad NFE exome
AF:
0.358
Gnomad OTH exome
AF:
0.364
GnomAD4 exome
AF:
0.362
AC:
528370
AN:
1460650
Hom.:
100230
Cov.:
44
AF XY:
0.359
AC XY:
260652
AN XY:
726732
show subpopulations
African (AFR)
AF:
0.829
AC:
27733
AN:
33458
American (AMR)
AF:
0.312
AC:
13953
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.371
AC:
9690
AN:
26128
East Asian (EAS)
AF:
0.274
AC:
10862
AN:
39672
South Asian (SAS)
AF:
0.300
AC:
25833
AN:
86228
European-Finnish (FIN)
AF:
0.285
AC:
15210
AN:
53380
Middle Eastern (MID)
AF:
0.409
AC:
2356
AN:
5766
European-Non Finnish (NFE)
AF:
0.359
AC:
399356
AN:
1110946
Other (OTH)
AF:
0.387
AC:
23377
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
19604
39208
58812
78416
98020
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12778
25556
38334
51112
63890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.478
AC:
72716
AN:
152074
Hom.:
20835
Cov.:
32
AF XY:
0.469
AC XY:
34850
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.811
AC:
33649
AN:
41496
American (AMR)
AF:
0.412
AC:
6301
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
1318
AN:
3472
East Asian (EAS)
AF:
0.281
AC:
1446
AN:
5152
South Asian (SAS)
AF:
0.283
AC:
1362
AN:
4816
European-Finnish (FIN)
AF:
0.280
AC:
2956
AN:
10574
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.357
AC:
24255
AN:
67954
Other (OTH)
AF:
0.478
AC:
1007
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1622
3244
4865
6487
8109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.401
Hom.:
20639
Bravo
AF:
0.500
Asia WGS
AF:
0.356
AC:
1241
AN:
3478
EpiCase
AF:
0.359
EpiControl
AF:
0.366

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 16, 2007
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 8 Benign:2
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.19
DANN
Benign
0.54
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2839501; hg19: chr21-43805637; COSMIC: COSV52302894; COSMIC: COSV52302894; API